Deuruxolitinib (Leqselvi, Sun Pharma) Is Now Available in the U.S. for Patients With Severe Alopecia Areata
Deuruxolitinib (Leqselvi, Sun Pharma) is now available in the U.S. for severe alopecia areata. Deuruxolitinib is an oral selective inhibitor of Janus kinases JAK1 and JAK2. It is the third JAK inhibitor approved to treat alopecia areata. Deuruxolitinib 8mg tablets demonstrated rapid results in clinical trials with one-third of patients regaining almost all of their […]